Barclays
CYNA

Barclays’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Barclays’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100
Closed -$2K – 6720
2015
Q4 		$2K Buy
+100
New +$1.52K ﹤0.01% 5790
2015
Q3 		– Sell
-112
Closed -$2K – 7275
2015
Q2 		$2K Buy
+112
New +$1.84K ﹤0.01% 6878

Other funds holding CYNA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Barclays's CYNA Position: Q1 2016 in Review

Barclays sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q1 2016, closing a stake of 100 shares — an estimated $2K sold.

Barclays first reported a position in CYNA in Q2 2015 and held it in 2 quarters. The position peaked at $2K in Q4 2015. 31 funds tracked by Wall St. Rank hold CYNA as of Q1 2016.

  • Barclays reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 100 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q1 2016, an estimated $2K.
  • Barclays first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 2 quarters.
  • Barclays's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $2K in Q4 2015.
  • 31 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.